Amanda W. Lund

6.3k total citations · 3 hit papers
61 papers, 3.4k citations indexed

About

Amanda W. Lund is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Amanda W. Lund has authored 61 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 24 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Amanda W. Lund's work include Lymphatic System and Diseases (19 papers), Immunotherapy and Immune Responses (16 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Amanda W. Lund is often cited by papers focused on Lymphatic System and Diseases (19 papers), Immunotherapy and Immune Responses (16 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Amanda W. Lund collaborates with scholars based in United States, Switzerland and Japan. Amanda W. Lund's co-authors include Melody A. Swartz, Jan P. Stegemann, George E. Plopper, Susan N. Thomas, Haley du Bois, Jeffrey A. Hubbell, Sachiko Hirosue, Vidya Raghavan, Stéphanie Hugues and Bülent Yener and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Amanda W. Lund

57 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity

2012 428 citations Melody A. Swartz, Amanda W. Lund Nature reviews. Cancer profile →
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment

2022 235 citations Ian Dryg, Amanda W. Lund et al. profile →
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas

2024 52 citations Emily Ko, Jin-Fen Xiao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda W. Lund United States	27	1.7k	1.1k	1.0k	730	414	61	3.4k
Shan Liao China	27	1.4k 0.8×	984 0.9×	1.2k 1.1×	382 0.5×	503 1.2×	79	3.3k
Anton C. Martens Netherlands	34	2.2k 1.3×	1.3k 1.2×	2.1k 2.0×	605 0.8×	511 1.2×	154	5.4k
Bart Vandekerckhove Belgium	37	1.0k 0.6×	2.0k 1.8×	1.8k 1.7×	275 0.4×	525 1.3×	132	4.4k
Chuan Tong China	28	1.6k 0.9×	711 0.6×	1.1k 1.0×	514 0.7×	313 0.8×	42	3.0k
Genevieve M. Boland United States	30	2.3k 1.3×	1.4k 1.3×	2.1k 2.1×	413 0.6×	781 1.9×	121	5.6k
Michele Cilli Italy	37	933 0.5×	658 0.6×	2.0k 1.9×	439 0.6×	221 0.5×	108	4.0k
Takashi Murakami Japan	45	2.1k 1.2×	1.2k 1.1×	1.8k 1.7×	1.5k 2.1×	874 2.1×	233	6.7k
Chen‐Hsiang Kuan Taiwan	14	896 0.5×	1.5k 1.4×	2.4k 2.3×	541 0.7×	496 1.2×	36	5.2k
Heather E. Fleming United States	26	601 0.3×	970 0.9×	1.8k 1.7×	625 0.9×	351 0.8×	42	4.0k

Countries citing papers authored by Amanda W. Lund

Since Specialization

Citations

This map shows the geographic impact of Amanda W. Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda W. Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda W. Lund more than expected).

Fields of papers citing papers by Amanda W. Lund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda W. Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda W. Lund. The network helps show where Amanda W. Lund may publish in the future.

Co-authorship network of co-authors of Amanda W. Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda W. Lund. A scholar is included among the top collaborators of Amanda W. Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda W. Lund. Amanda W. Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foster, Connor, Jasper Du, Mitchell J. Geer, et al.. (2025). T lymphocyte–specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4 ⁺ T cells and impairs antitumor response. Proceedings of the National Academy of Sciences. 122(29). e2427254122–e2427254122.

Alcolea, Maria P., Direna Alonso‐Curbelo, Chiara Ambrogio, et al.. (2024). Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discovery. 14(4). 674–682. 7 indexed citations

Karakousi, Triantafyllia, Tenny Mudianto, & Amanda W. Lund. (2024). Lymphatic vessels in the age of cancer immunotherapy. Nature reviews. Cancer. 24(6). 363–381. 17 indexed citations

Ko, Emily, Jin-Fen Xiao, Marco De Simone, et al.. (2024). Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nature Communications. 15(1). 2498–2498. 52 indexed citations breakdown →

Schneider, Elizabeth M., et al.. (2023). Telehealth Utilization in High-Risk Pregnancies During COVID-19. SHILAP Revista de lepidopterología. 4(1). 61–66. 1 indexed citations

Steele, Maria M., Ian Dryg, Dhaarini Murugan, et al.. (2023). T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nature Immunology. 24(4). 664–675. 71 indexed citations

Kim, Sungsoo, Subrata Chowdhury, Carrie J. Shawber, et al.. (2023). Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma. Cancer Research. 83(12). 1968–1983. 24 indexed citations

Bois, Haley du, et al.. (2023). Abstract 3511: Melanoma-shed, lymph-borne CSPG4 conditions the pre-metastatic lymph node niche. Cancer Research. 83(7_Supplement). 3511–3511. 1 indexed citations

Churchill, Madeline J., Haley du Bois, Tenny Mudianto, et al.. (2022). Infection-induced lymphatic zippering restricts fluid transport and viral dissemination from skin. The Journal of Experimental Medicine. 219(5). 29 indexed citations

10.

Lund, Amanda W.. (2022). Immune Potential Untapped: Leveraging the Lymphatic System for Cancer Immunotherapy. Cancer Immunology Research. 10(9). 1042–1046. 9 indexed citations

11.

Blair, Tiffany C., Shelly Bambina, Gwen Kramer, et al.. (2022). Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy. Life Science Alliance. 5(9). e202101337–e202101337. 22 indexed citations

12.

Ngamcherdtrakul, Worapol, Moataz Reda, Molly A. Nelson, et al.. (2021). In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response. Advanced Materials. 33(31). e2100628–e2100628. 61 indexed citations

13.

Yu, Wesley Y., E. Ricky Chan, John J. Pink, et al.. (2021). Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma. Journal of Investigative Dermatology. 141(7). 1802–1809. 7 indexed citations

14.

Leachman, Sancy A., Thomas J. Hornyak, Gregory S. Barsh, et al.. (2019). Melanoma to Vitiligo: The Melanocyte in Biology & Medicine–Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting. Journal of Investigative Dermatology. 140(2). 269–274. 4 indexed citations

15.

Lane, Ryan S., Julia Femel, Christopher P. Loo, et al.. (2018). IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. The Journal of Experimental Medicine. 215(12). 3057–3074. 126 indexed citations

16.

Fankhauser, Manuel, Maria A.S. Broggi, Lambert Potin, et al.. (2017). Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Science Translational Medicine. 9(407). 190 indexed citations

17.

Güç, Esra, Manuel Fankhauser, Amanda W. Lund, Melody A. Swartz, & Witold W. Kilarski. (2014). Long-term Intravital Immunofluorescence Imaging of Tissue Matrix Components with Epifluorescence and Two-photon Microscopy. Journal of Visualized Experiments. 16 indexed citations

18.

Kilarski, Witold W., Esra Güç, Jeremy Teo, et al.. (2013). Intravital Immunofluorescence for Visualizing the Microcirculatory and Immune Microenvironments in the Mouse Ear Dermis. PLoS ONE. 8(2). e57135–e57135. 53 indexed citations

19.

Lund, Amanda W., et al.. (2010). Quantification of Three-Dimensional Cell-Mediated Collagen Remodeling Using Graph Theory. PLoS ONE. 5(9). e12783–e12783. 16 indexed citations

20.

Lund, Amanda W., et al.. (2008). Osteogenic differentiation of mesenchymal stem cells in defined protein beads. Journal of Biomedical Materials Research Part B Applied Biomaterials. 87B(1). 213–221. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact